DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Von Minckwitz G, Chiun-Sheng H, Mano MS. et al
Trastuzumab Emtansine for Residual Invasive Her2-Positive Breast Cancer.
N Engl J Med 2019;
380: 617-628 . doi:10.1056/NEJMoa1814017
We do not assume any responsibility for the contents of the web pages of other providers.